Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
They mimic the GLP-1 hormone, which plays a role in appetite regulation and insulin production
Updated February 2026 Retatrutide vs CagriSema (Cagrilintide + Semaglutide): Triple Agonist vs Amylin + GLP-1 Combo Cagrilintide vs retatrutide: triple agonist vs amylin + GLP-1 combo 28.7% vs 22.7% weight loss, different receptors, and stacking considerations
These include being older, having enlarged lymph nodes for longer than 4 weeks, experiencing enlarged lymph nodes all over the body, being male, the lymph nodes not shrinking back to normal size, and showing systemic signs
The American Cancer Society and WHO's Global Cancer Statistics 2026 released earlier this month documented the scale of the chronic disease burden heading toward 2050
Note any changes in sleep patterns, blood pressure, or heart rhythm and report these to your doctor
Frias, et al., 'Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial', Nat
US$ 27.87
US$ 29.69
US$ 22.77
US$ 21.39
